Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats

This publication has 56 references indexed in Scilit:

• Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy
  American Journal of Physiology-Renal Physiology, 2008
• Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients
  Pharmacological Research, 2007
• Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-α stimulation, and effects of a phosphodiesterase inhibitor
  Life Sciences, 2007
• Genetic influences of the intercellular adhesion molecule 1 (ICAM‐1) gene polymorphisms in development of Type 1 diabetes and diabetic nephropathy
  Diabetic Medicine, 2006
• Cilostazol Protects Diabetic Rats from Vascular Inflammation via Nuclear Factor-κB-Dependent Down-Regulation of Vascular Cell Adhesion Molecule-1 Expression
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4
  American Journal of Physiology-Renal Physiology, 2004
• Compartmentalization of cAMP Signaling in Mesangial Cells by Phosphodiesterase Isozymes PDE3 and PDE4 REGULATION OF SUPEROXIDATION AND MITOGENESIS
  Journal of Biological Chemistry, 1997
• The Critical Role of Intercellular Adhesion Molecule-1 in Masugi Nephritis in Rats
  Nephron, 1996
• Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells.
  Journal of Clinical Investigation, 1995
• Structural-functional relationships in diabetic nephropathy.
  Journal of Clinical Investigation, 1984